297 related articles for article (PubMed ID: 34771575)
21. Bone morphogenetic protein (BMP) and activin type II receptors balance BMP9 signals mediated by activin receptor-like kinase-1 in human pulmonary artery endothelial cells.
Upton PD; Davies RJ; Trembath RC; Morrell NW
J Biol Chem; 2009 Jun; 284(23):15794-804. PubMed ID: 19366699
[TBL] [Abstract][Full Text] [Related]
22. Bone morphogenetic protein-9 is a circulating vascular quiescence factor.
David L; Mallet C; Keramidas M; Lamandé N; Gasc JM; Dupuis-Girod S; Plauchu H; Feige JJ; Bailly S
Circ Res; 2008 Apr; 102(8):914-22. PubMed ID: 18309101
[TBL] [Abstract][Full Text] [Related]
23. BMP9 and BMP10 are critical for postnatal retinal vascular remodeling.
Ricard N; Ciais D; Levet S; Subileau M; Mallet C; Zimmers TA; Lee SJ; Bidart M; Feige JJ; Bailly S
Blood; 2012 Jun; 119(25):6162-71. PubMed ID: 22566602
[TBL] [Abstract][Full Text] [Related]
24. ALK1Fc Suppresses the Human Prostate Cancer Growth in
Astrologo L; Zoni E; Karkampouna S; Gray PC; Klima I; Grosjean J; Goumans MJ; Hawinkels LJAC; van der Pluijm G; Spahn M; Thalmann GN; Ten Dijke P; Kruithof-de Julio M
Front Cell Dev Biol; 2017; 5():104. PubMed ID: 29259971
[TBL] [Abstract][Full Text] [Related]
25. Bone morphogenetic protein 9 (BMP9) controls lymphatic vessel maturation and valve formation.
Levet S; Ciais D; Merdzhanova G; Mallet C; Zimmers TA; Lee SJ; Navarro FP; Texier I; Feige JJ; Bailly S; Vittet D
Blood; 2013 Jul; 122(4):598-607. PubMed ID: 23741013
[TBL] [Abstract][Full Text] [Related]
26. TGF-β & BMP receptors endoglin and ALK1: overview of their functional role and status as antiangiogenic targets.
Jonker L
Microcirculation; 2014 Feb; 21(2):93-103. PubMed ID: 25279424
[TBL] [Abstract][Full Text] [Related]
27. Genetic and pharmacological targeting of activin receptor-like kinase 1 impairs tumor growth and angiogenesis.
Cunha SI; Pardali E; Thorikay M; Anderberg C; Hawinkels L; Goumans MJ; Seehra J; Heldin CH; ten Dijke P; Pietras K
J Exp Med; 2010 Jan; 207(1):85-100. PubMed ID: 20065063
[TBL] [Abstract][Full Text] [Related]
28. Activin Receptor-like kinase 1: a novel anti-angiogenesis target from TGF-β family.
Vecchia L; Olivieri C; Scotti C
Mini Rev Med Chem; 2013 Aug; 13(10):1398-406. PubMed ID: 23815578
[TBL] [Abstract][Full Text] [Related]
29. Bone morphogenetic protein‑9 promotes the differentiation of mouse spleen macrophages into osteoclasts via the ALK1 receptor and ERK 1/2 pathways in vitro.
Li H; Zhao D; Wang S; Ding J; Zhao L
Mol Med Rep; 2016 Nov; 14(5):4545-4550. PubMed ID: 27748860
[TBL] [Abstract][Full Text] [Related]
30. Targeting vascular normalization: a promising strategy to improve immune-vascular crosstalk in cancer immunotherapy.
Qian C; Liu C; Liu W; Zhou R; Zhao L
Front Immunol; 2023; 14():1291530. PubMed ID: 38193080
[TBL] [Abstract][Full Text] [Related]
31. Metformin inhibits ALK1-mediated angiogenesis via activation of AMPK.
Ying Y; Ueta T; Jiang S; Lin H; Wang Y; Vavvas D; Wen R; Chen YG; Luo Z
Oncotarget; 2017 May; 8(20):32794-32806. PubMed ID: 28427181
[TBL] [Abstract][Full Text] [Related]
32. Broad targeting of angiogenesis for cancer prevention and therapy.
Wang Z; Dabrosin C; Yin X; Fuster MM; Arreola A; Rathmell WK; Generali D; Nagaraju GP; El-Rayes B; Ribatti D; Chen YC; Honoki K; Fujii H; Georgakilas AG; Nowsheen S; Amedei A; Niccolai E; Amin A; Ashraf SS; Helferich B; Yang X; Guha G; Bhakta D; Ciriolo MR; Aquilano K; Chen S; Halicka D; Mohammed SI; Azmi AS; Bilsland A; Keith WN; Jensen LD
Semin Cancer Biol; 2015 Dec; 35 Suppl(Suppl):S224-S243. PubMed ID: 25600295
[TBL] [Abstract][Full Text] [Related]
33. Impact of selective anti-BMP9 treatment on tumor cells and tumor angiogenesis.
Brand V; Lehmann C; Umkehrer C; Bissinger S; Thier M; de Wouters M; Raemsch R; Jucknischke U; Haas A; Breuer S; Birzele F; Racek T; Reis M; Lorenzon E; Herting F; Stürzl M; Lorenz S; Kienast Y
Mol Oncol; 2016 Dec; 10(10):1603-1620. PubMed ID: 28949445
[TBL] [Abstract][Full Text] [Related]
34. A heterodimer formed by bone morphogenetic protein 9 (BMP9) and BMP10 provides most BMP biological activity in plasma.
Tillet E; Ouarné M; Desroches-Castan A; Mallet C; Subileau M; Didier R; Lioutsko A; Belthier G; Feige JJ; Bailly S
J Biol Chem; 2018 Jul; 293(28):10963-10974. PubMed ID: 29789425
[TBL] [Abstract][Full Text] [Related]
35. Dual targeting of vascular endothelial growth factor and bone morphogenetic protein-9/10 impairs tumor growth through inhibition of angiogenesis.
Akatsu Y; Yoshimatsu Y; Tomizawa T; Takahashi K; Katsura A; Miyazono K; Watabe T
Cancer Sci; 2017 Jan; 108(1):151-155. PubMed ID: 28133920
[TBL] [Abstract][Full Text] [Related]
36. Exploring Novel Methods for Modulating Tumor Blood Vessels in Cancer Treatment.
Wong PP; Bodrug N; Hodivala-Dilke KM
Curr Biol; 2016 Nov; 26(21):R1161-R1166. PubMed ID: 27825457
[TBL] [Abstract][Full Text] [Related]
37. Normalization of the vasculature for treatment of cancer and other diseases.
Goel S; Duda DG; Xu L; Munn LL; Boucher Y; Fukumura D; Jain RK
Physiol Rev; 2011 Jul; 91(3):1071-121. PubMed ID: 21742796
[TBL] [Abstract][Full Text] [Related]
38. BMP10-mediated ALK1 signaling is continuously required for vascular development and maintenance.
Capasso TL; Li B; Volek HJ; Khalid W; Rochon ER; Anbalagan A; Herdman C; Yost HJ; Villanueva FS; Kim K; Roman BL
Angiogenesis; 2020 May; 23(2):203-220. PubMed ID: 31828546
[TBL] [Abstract][Full Text] [Related]
39. Vascular injury triggers Krüppel-like factor 6 mobilization and cooperation with specificity protein 1 to promote endothelial activation through upregulation of the activin receptor-like kinase 1 gene.
Garrido-Martín EM; Blanco FJ; Roquè M; Novensà L; Tarocchi M; Lang UE; Suzuki T; Friedman SL; Botella LM; Bernabéu C
Circ Res; 2013 Jan; 112(1):113-27. PubMed ID: 23048070
[TBL] [Abstract][Full Text] [Related]
40. A mouse model of hereditary hemorrhagic telangiectasia generated by transmammary-delivered immunoblocking of BMP9 and BMP10.
Ruiz S; Zhao H; Chandakkar P; Chatterjee PK; Papoin J; Blanc L; Metz CN; Campagne F; Marambaud P
Sci Rep; 2016 Nov; 5():37366. PubMed ID: 27874028
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
